186 related articles for article (PubMed ID: 21784485)
1. B7-H3 over expression in prostate cancer promotes tumor cell progression.
Yuan H; Wei X; Zhang G; Li C; Zhang X; Hou J
J Urol; 2011 Sep; 186(3):1093-9. PubMed ID: 21784485
[TBL] [Abstract][Full Text] [Related]
2. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.
Roth TJ; Sheinin Y; Lohse CM; Kuntz SM; Frigola X; Inman BA; Krambeck AE; McKenney ME; Karnes RJ; Blute ML; Cheville JC; Sebo TJ; Kwon ED
Cancer Res; 2007 Aug; 67(16):7893-900. PubMed ID: 17686830
[TBL] [Abstract][Full Text] [Related]
3. Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population?
Liu Y; Vlatkovic L; Sæter T; Servoll E; Waaler G; Nesland JM; Giercksky KE; Axcrona K
Int J Urol; 2012 Aug; 19(8):749-56. PubMed ID: 22487487
[TBL] [Abstract][Full Text] [Related]
4. Re: B7-H3 over expression in prostate cancer promotes tumor cell progression: H. Yuan, X. Wei, G. Zhang, C. Li, X. Zhang And J. Hou; J Urol 2011; 186: 1093-1099.
Kapoor S
J Urol; 2012 Dec; 188(6):2437; author reply 2438. PubMed ID: 23088979
[No Abstract] [Full Text] [Related]
5. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis.
Xu YH; Zhang GB; Wang JM; Hu HC
Saudi Med J; 2010 Sep; 31(9):980-6. PubMed ID: 20844808
[TBL] [Abstract][Full Text] [Related]
6. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells.
Arigami T; Uenosono Y; Hirata M; Yanagita S; Ishigami S; Natsugoe S
Cancer Sci; 2011 May; 102(5):1019-24. PubMed ID: 21251161
[TBL] [Abstract][Full Text] [Related]
7. High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth.
Ruiz C; Oeggerli M; Germann M; Gluderer S; Stocker H; Andreozzi M; Thalmann GN; Cecchini MG; Zellweger T; Stürm S; Koivisto PA; Helin HJ; Gelmann EP; Glass AG; Gasser TC; Terracciano LM; Bachmann A; Wyler S; Bubendorf L; Rentsch CA
Prostate; 2012 Nov; 72(15):1678-87. PubMed ID: 22473923
[TBL] [Abstract][Full Text] [Related]
8. B7-H3 overexpression in pancreatic cancer promotes tumor progression.
Zhao X; Li DC; Zhu XG; Gan WJ; Li Z; Xiong F; Zhang ZX; Zhang GB; Zhang XG; Zhao H
Int J Mol Med; 2013 Feb; 31(2):283-91. PubMed ID: 23242015
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R
Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309
[TBL] [Abstract][Full Text] [Related]
10. Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis.
Katayama A; Takahara M; Kishibe K; Nagato T; Kunibe I; Katada A; Hayashi T; Harabuchi Y
Int J Oncol; 2011 May; 38(5):1219-26. PubMed ID: 21344157
[TBL] [Abstract][Full Text] [Related]
11. Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications.
Calabrò L; Sigalotti L; Fonsatti E; Bertocci E; Di Giacomo AM; Danielli R; Cutaia O; Colizzi F; Covre A; Mutti L; Natali PG; Maio M
J Cell Physiol; 2011 Oct; 226(10):2595-600. PubMed ID: 21792917
[TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
Das S; Roth CP; Wasson LM; Vishwanatha JK
Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
14. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
[TBL] [Abstract][Full Text] [Related]
15. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
16. B7-H3 and B7-H4 expression in non-small-cell lung cancer.
Sun Y; Wang Y; Zhao J; Gu M; Giscombe R; Lefvert AK; Wang X
Lung Cancer; 2006 Aug; 53(2):143-51. PubMed ID: 16782226
[TBL] [Abstract][Full Text] [Related]
17. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
[TBL] [Abstract][Full Text] [Related]
18. 4IgB7-H3 is the major isoform expressed on immunocytes as well as malignant cells.
Zhou YH; Chen YJ; Ma ZY; Xu L; Wang Q; Zhang GB; Xie F; Ge Y; Wang XF; Zhang XG
Tissue Antigens; 2007 Aug; 70(2):96-104. PubMed ID: 17610414
[TBL] [Abstract][Full Text] [Related]
19. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
[TBL] [Abstract][Full Text] [Related]
20. Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer.
Segawa Y; Yoshimura R; Hase T; Nakatani T; Wada S; Kawahito Y; Kishimoto T; Sano H
Prostate; 2002 May; 51(2):108-16. PubMed ID: 11948965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
